| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Property | Definition | Usage | Example | Dataset#1 | Dataset#2 | Dataset#3 | |||||||||||||||||||
2 | Dataset Discovery | M | Title | A clear and concise name for the dataset. | The name can be repeated for multiple languages. | Open Challenge Prostate Cancer V1 | ||||||||||||||||||||
3 | M | Description | A detailed description of the dataset's content, purpose, and scope. | The description can be repeated for multiple languages. | This prostate cancer imaging dataset contains a collection of patients with mpMRI examinations (T2 Axial, DWI, ADC) who have confirmed prostate cancer at biopsy and/or prostatectomy. | |||||||||||||||||||||
4 | M | Provenance | A statement about the lineage of a Dataset. | Information about how the data was collected, including methodologies, tools, and protocols used. | This data is sourced from several existing datasets, including the Duke dataset, ParcTauli and TCGA datasets, which got harmonized and annotated by radiologist experts. | |||||||||||||||||||||
5 | M | Intended Purpose | The primary objective for which the dataset was created. | A free text statement of the purpose of the processing of data or personal data. | The primary objective of this dataset is the detection of prostate cancer with high accuracy both in peripheral and transitional zones to identify which men have cancer and those with no cancer. | |||||||||||||||||||||
6 | M | Image Creation Year(s) | A temporal period that the dataset covers. This corresponds to the year range that the actual (DICOM) images were created/acquired. The startDate and endDate should be added. | This can be extracted from the DICOM acquisition date (0008,0022), if this has not been changed/removed in the anonymization process. If this is not available, an approximation should be added. | startDate: 2021-01-01, endDate: 2024-12-31 | |||||||||||||||||||||
7 | M | Geographical Coverage | A geographic region that is covered by the Dataset. | Country names are recommended, or any other spatial coverage, e.g. Europe | Spain, Greece, Italy, Germany | |||||||||||||||||||||
8 | Contacts | M | Contact Point | Contact information of the individual/managing organization of the Dataset for sending comments about the Dataset. | Contact information should include the contact email and/or the contact page. At least one of the two MUST be provided. Additionally the following information can be provided: Name, URL, Organization Name, Organization Unit. In case the dataset is transferred to one of the reference nodes, the Data Access Committee will be designated as the contact point. | Name: Valia Kalokyri, Email: vkalokyri@ics.forth.gr, Organization: Foundation for Research and Technology (Hellas) | ||||||||||||||||||||
9 | M | Publisher | An entity (organisation) responsible for making the Dataset available. (Name and URL (landing page) of the organisation should be given) | Name: University Hospital of Heraklion, URL: https://www.pagni.gr/ | ||||||||||||||||||||||
10 | M | Publisher Type | A type of organisation that makes the Dataset available. | One of: Research Institute, Hospital or Healthcare System, National Public Health Institute, Biobank, International Health Organization, Repository, European project, Cancer screening program, Patient association, Data altruism organization, ERIC and EDIC. | Hospital or Healthcare System | |||||||||||||||||||||
11 | Domain specific metadata | M | Applicable Legislation | The legislation that mandates the creation or management of the Dataset. | The value must include the ELI of the EHDS Regulation. Multiple legislations may apply to the dataset. | https://eur-lex.europa.eu/eli/reg/2022/868/oj (ELI of the Data Governance Act) | ||||||||||||||||||||
12 | M | Theme | A category of the dataset. | The value is fixed to "HEALTH" | HEALTH | |||||||||||||||||||||
13 | M | Type | A type of the Dataset. | One of Original Dataset, Annotated Dataset, Processed Dataset. The value “PersonalData” will also be registered by default. | Annotated Dataset, Processed Dataset | |||||||||||||||||||||
14 | M | Age low | The minimum age of subjects within the dataset. | 18 | ||||||||||||||||||||||
15 | M | Age high | The maximum age of subjects within the dataset. | 78 | ||||||||||||||||||||||
16 | M | Birth sex | BirthSex of subjects in the dataset. | One of Female, Male, Unspecified | Female, Male | |||||||||||||||||||||
17 | M | Number of Studies | Total count of DICOM studies. | 8789 | ||||||||||||||||||||||
18 | M | Number of Subjects | Total count of unique individuals in the dataset. | 8237 | ||||||||||||||||||||||
19 | M | Collection Method | This attribute defines the scope of data aggregation within the dataset. It specifies how data records are organized based on different criteria, allowing users to understand the context in which the data was collected. | One of: Patient-based, Cohort, Only-Image, Longitudinal, Case-control, Disease-specific | Cohort, Longitudinal | |||||||||||||||||||||
20 | M | Quality label | A statement related to quality of the Dataset, including rating, quality certificate as per the EHDS requirements. | |||||||||||||||||||||||
21 | R | Legal Basis | Legal basis used to justify processing of data or use of technology in accordance with a law. | |||||||||||||||||||||||
22 | M | Condition | The primary cancer condition of individuals in the dataset. | ICD-10, SNOMED | Malignant neoplasm of prostate | |||||||||||||||||||||
23 | M | Image Modality | The set of modalities for the images in the dataset, as defined in DICOM tag (0008,0060) | Magnetic Resonance Imaging | ||||||||||||||||||||||
24 | M | Image Equipment Manufacturer | Manufacturer of the imaging device as it is defined in DICOM tag (0008,0070). | Siemens, Philips, GE | ||||||||||||||||||||||
25 | M | Image Body Part | Anatomical areas captured in the images as defined in DICOM tag : 0018,0015 | Pelvis, Abdomen | ||||||||||||||||||||||
26 | Dataset distribution | M | Access URL | A URL that gives information about accessing the dataset. | In case the dataset has been transfered to the EUCAIM reference node, this is the URL of the negotiator service for the specific dataset. If the access will be given through a local node negotiation process, this will be the landing page of the organization supporting data access. | https://negotiator.eucaim.cancerimage.eu/collection/a96b56cd-59d4-444a-8e59-32a7fb0d7dea | ||||||||||||||||||||
27 | M | Access Rights | The accessRights of the dataset. | One of the public, non-public, restricted. Please check D4.4 Annex 2 for more information. | Non-public | |||||||||||||||||||||
28 | M | Access Conditions | A statement about the conditions of access and usage of the dataset. | One of: “Authorisation to download the datasets” “Authorisation to access, view and process in-situ the datasets” “Authorisation to remotely process the datasets without the ability to access and visualise data, even remotely.”" | Authorisation to access, view and process in-situ the datasets | |||||||||||||||||||||
29 | M | ImageSize (in GB) | The total size of all Distributions in the dataset, which is mainly the image size. | 325 GB | ||||||||||||||||||||||
30 | M | Format | The file format of the Distributions included in the Dataset. | Imaging data: the imaging format of the images in your dataset (e.g. DICOM, Nifti), Annotation data: the format of the annotations (e.g. DICOM-SEG, Nifti), if available. Clinical data: the format of the available clinical data (e.g. CSV, XLS, JSON, parquet). | Imaging: DICOM, Clinical: CSV, Annotations: DICOM-SEG | |||||||||||||||||||||
31 | R | Compression Format (if applicable) | The format of the file in which the data is contained in a compressed form. (e.g. .zip file containing the images and clinical data) | GZIP | ||||||||||||||||||||||
32 | R | Packaging Format (if applicable) | The format of the file in which the data files are grouped together, e.g. to enable a set of related files to be downloaded together. | TAR | ||||||||||||||||||||||
33 | M | Sample | A sample distribution of the dataset. Only the downloadURL of the sample distribution is required. | At least one sample Distribution of the dataset should be available. These samples could be a synthetic subset or representative examples of the dataset to facilitate evaluation and understanding or even solely exhibit the dataset's structure, i.e. human-readable structural metadata providing the properties or columns of the dataset schema. Providing such a sample as a downloadable file can offer insights into the data's format, structure and set of values, aiding in understanding and utilisation while ensuring privacy and security. | https://exampleFileDownload.csv | |||||||||||||||||||||
34 | Technical Metadata | M | Identifier | A unique identifier for the dataset. In the context of EUCAIM, this is the URI in the context of the EUCAIM Public Catalogue (persistent dereferenceable URIs). | https://catalogue.eucaim.cancerimage.eu/#/collection/1a1a6653-975a-4a0a-a79b-b2bfc7317119 | |||||||||||||||||||||
35 | M | Version | The version of the dataset. | in SemVer or CalVer format | 20231122 or v1.2 | |||||||||||||||||||||
36 | M | Interoperability Tier | The EUCAIM data federation and interoperability tier the specific dataset belongs to. | One of “Tier 1”, “Tier 2”, “Tier 3”, “Tier 1A+”, “Tier 1C+”, “Tier 2A+”,”Tier 2C+”, “Tier 3A+”, “Tier3C+“. | Tier1 | |||||||||||||||||||||
37 | ||||||||||||||||||||||||||
38 | ||||||||||||||||||||||||||
39 | ||||||||||||||||||||||||||
40 | ||||||||||||||||||||||||||
41 | ||||||||||||||||||||||||||
42 | ||||||||||||||||||||||||||
43 | ||||||||||||||||||||||||||
44 | ||||||||||||||||||||||||||
45 | ||||||||||||||||||||||||||
46 | ||||||||||||||||||||||||||
47 | ||||||||||||||||||||||||||
48 | ||||||||||||||||||||||||||
49 | ||||||||||||||||||||||||||
50 | ||||||||||||||||||||||||||
51 | ||||||||||||||||||||||||||
52 | ||||||||||||||||||||||||||
53 | ||||||||||||||||||||||||||
54 | ||||||||||||||||||||||||||
55 | ||||||||||||||||||||||||||
56 | ||||||||||||||||||||||||||
57 | ||||||||||||||||||||||||||
58 | ||||||||||||||||||||||||||
59 | ||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||
61 | ||||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||
63 | ||||||||||||||||||||||||||
64 | ||||||||||||||||||||||||||
65 | ||||||||||||||||||||||||||
66 | ||||||||||||||||||||||||||
67 | ||||||||||||||||||||||||||
68 | ||||||||||||||||||||||||||
69 | ||||||||||||||||||||||||||
70 | ||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||
100 |